Curcumin and piperine abrogate lipid and protein oxidation induced by D-galactose in rat brain D Banji, OJF Banji, S Dasaroju, KK Ch Brain research 1515, 1-11, 2013 | 66 | 2013 |
Zingerone regulates intestinal transit, attenuates behavioral and oxidative perturbations in irritable bowel disorder in rats D Banji, OJF Banji, B Pavani, CK Kumar, AR Annamalai Phytomedicine 21 (4), 423-429, 2014 | 63 | 2014 |
Combination of carvacrol with methotrexate suppresses Complete Freund's Adjuvant induced synovial inflammation with reduced hepatotoxicity in rats OJF Banji, D Banji, N Soumya, KK Chilipi, CH Kalpana, CHK Kumar, ... European journal of pharmacology 723, 91-98, 2014 | 30 | 2014 |
CtBP—a targetable dependency for tumor-initiating cell activity and metastasis in pancreatic adenocarcinoma AT Chawla, KK Chougoni, PJ Joshi, AD Cororaton, P Memari, ... Oncogenesis 8 (10), 55, 2019 | 20 | 2019 |
Extraction of high-quality RNA from mouse pancreatic tumors KK Chougoni, SR Grossman MethodsX 7, 101163, 2020 | 6 | 2020 |
Sensitizing oncogenic mutant p53-expressing non-small cell lung cancer to proteasome inhibitors KK Chougoni, VL Neely, B Ding, E Oduah, K Nguyen, B Hu, J Koblinski, ... Cancer Research 83 (7_Supplement), 3950-3950, 2023 | 2 | 2023 |
Coordinate transcriptional regulation of ErbB2/3 by C-terminal binding protein 2 signals sensitivity to ErbB2 inhibition in pancreatic adenocarcinoma KK Chougoni, H Park, PK Damle, T Mason, B Cheng, MM Dcona, ... Oncogenesis 12 (1), 53, 2023 | 1 | 2023 |
p38-p14ARF-CtBP2 axis as a novel regulator of CSC phenotype and tumor cell dormancy RS Boothello, NJ Patel, PK Damle, C Sharon, KK Chougoni, UR Desai, ... Cancer Research 78 (13_Supplement), 3460-3460, 2018 | 1 | 2018 |
Novel in-vitro and in-vivo strategies to study pancreatic ductal adenocarcinoma progression and chemoresistance KK Chougoni Frontiers in Cell and Developmental Biology 12, 1435209, 2024 | | 2024 |
Orthogonal targeting of NAD metabolism and ErbB2/ErbB3 signaling in pancreatic adenocarcinoma KK Chougoni, N Kim, MM Dcona, DT Dcona, GK Malhotra, SR Grossman Cancer Research 84 (6_Supplement), 7217-7217, 2024 | | 2024 |
Oncogenic Mutant p53 Sensitizes Non-Small Cell Lung Cancer Cells to Proteasome Inhibition via Oxidative Stress-Dependent Induction of Mitochondrial Apoptosis KK Chougoni, V Neely, B Ding, E Oduah, V Lam, B Hu, JE Koblinski, ... bioRxiv, 2024.02. 22.581532, 2024 | | 2024 |
Combined targeting of NAD biosynthesis and the NAD-dependent transcription factor C-terminal Binding Protein as a promising novel therapy for pancreatic cancer MM Dcona, KK Chougoni, DT Dcona, JL West, SJ Singh, KC Ellis, ... Cancer Research Communications 3 (10), 2003-2013, 2023 | | 2023 |
C-terminal Binding Protein (CtBP): a critical regulator of ErbB2/3 signaling in PDAC. KK Chougoni, H Park, PK Damle, MM Dcona, B Szomju, MG Dozmorov, ... CANCER RESEARCH 82 (22), 106-106, 2022 | | 2022 |
Investigating the role of oncogene C-terminal Binding Protein (CtBP) in Pancreatic Ductal Adenocarcinoma KK Chougoni | | 2020 |